OBN Member and near neighbour Adaptimmune Therapeutics has announced plans to expand its research and development operation into a major new purpose-built facility at Milton Park.

Construction of the 67,000 square foot 'Enterprise Zone' building is already under way following a traditional groundbreaking ceremony. The flagship facility will provide laboratory space with associated offices, meeting rooms and a café area to accommodate a team of around 200 highly-skilled research and development specialists.

The new building is designed to support the Company's continuing growth of its research and development operation and is scheduled for delivery in late 2016. Click here for more information.